methylprednisolone hemisuccinate has been researched along with bicalutamide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
DiFabrizio, L; Macris, N; Seriff, NS; Wong, PW | 1 |
Sakai, N; Shioi, K; Yoshida, M | 1 |
Nakamura, M; Sakai, N; Shioi, K; Yoshida, M | 1 |
1 review(s) available for methylprednisolone hemisuccinate and bicalutamide
Article | Year |
---|---|
Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.
Topics: Aged; Androgen Antagonists; Anilides; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Biopsy; Dyspnea; Glucocorticoids; Humans; Lung Diseases, Interstitial; Male; Methylprednisolone Hemisuccinate; Nitriles; Prostatic Neoplasms; Pulmonary Eosinophilia; Tosyl Compounds | 1998 |
3 other study(ies) available for methylprednisolone hemisuccinate and bicalutamide
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Interstitial pneumonitis induced by bicalutamide and leuprorelin acetate for prostate cancer.
Topics: Aged; Anilides; Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Glucocorticoids; Humans; Leuprolide; Lung Diseases, Interstitial; Male; Methylprednisolone Hemisuccinate; Nitriles; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2003 |
Successful recovery from interstitial pneumonitis, induced by bicalutamide and leuprorelin acetate given as treatment for prostate cancer.
Topics: Adenocarcinoma; Aged; Anilides; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Bone Neoplasms; Humans; Leuprolide; Lung Diseases, Interstitial; Male; Methylprednisolone Hemisuccinate; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2005 |